Beta

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

As it turns six, crypto platform BYDFi expands into traditional finance, bolsters global regulatory compliance, and launches a $1M anniversary event.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

CI Global Asset Management launches innovative funds combining crypto's growth and gold's stability, challenging traditional diversification with a 0% fee offer.